Introduction
Recent advances in metabolic profiling technologies by providing quantitative measures of metabolite profiles from gas chromatography time-of-flight mass spectrometry (GC-TOF-MS) based technology present the opportunity to apply this technique in human specimens
. Global metabolic profiling has emerged as a promising approach to characterize the metabolite pool within a cell, tissue or bodily fluid under certain conditions, such as health or disease status [4, 6, 7] . Metabolic profiling is applied to monitor the health to disease continuum and has the potential of increasing our understanding of the mechanisms of disease [8] . 3.25) and peaks with a signal to noise ratio Ͼ10 were exported before using an algorithm developed in-house for dealing with the output.txt files [9] . Mass spectra were compared to an in-house mass spectral library for metabolite identification and peak heights expressed relative to an internal standard ( 13 C sorbitol-D) . [9] . Metabolites with more than 20% missing values were excluded and remaining missing values were estimated via BPCA using the R package pcaMethods [10] 
Thus the characterization of the metabolic features in tumours is expected to provide a better understanding of the mechanisms of malignant transformation and progression and may lead to the identification of metabolic biomarkers for cancer detection and prognostication. However, comparative profiling of low molecular weight compounds, such as sugars, lipids and amino acids, in cancer as compared to the corresponding normal tissue is a rather unexplored area. The objective of this study was to characterize the key metabolic features of RCC using GC-TOF-MS and mutual information as well as decision tree-based data analysis.

Material and methods
Study population and sample collection
Sample preparation and GC-TOF-MS analysis
Statistical analysis
1). Thus this model was selected for validation using the second dataset, where it resulted in 77% correct classification. This is less than the 95% observed for the first dataset, but is however, very similar to the classification reached within the second dataset itself (75% with the ADTree with 10-fold cross-validation).
Tree-based learning algorithms in particular, are designed to the selection of the single best classifier at each decision step and therefore occasionally prone to the exclusion of others which could themselves carry potentially meaningful information (Fig. 2) 
Discussion
This study characterizes the metabolite pool of RCC as compared to control renal cortex tissue using non-targeted metabolic profiling and permitted the assignment of a specific metabolic signature to RCC. This signature was not only validated with common test procedures, but was also confirmed in an independent, subsequently compiled validation dataset. Thus a set of key metabolites representing relevant metabolic pathways of RCC was established. Our data together with a previous study [12] substantially extend the knowledge on the small molecule component of RCC tissue. These findings complement earlier studies on biomarker discovery in RCC using 'omics' platforms [13] [14] [15] .
As [17, 18] . Using a combination of transcriptomics and proteomics it has been recently confirmed that genes and proteins involved in cellular metabolism play a crucial part in the development and progression of RCC making them promising candidates for biomarker identification [15] .
To compensate for their high energy demands, cancer cells are likely to exploit a multitude of energy sources including fatty acid oxidation and other non-glycolytic pathways [19, 20] . According to our findings, metabolites of fatty acid metabolism seem to play a key part in RCC metabolism. A number of fatty acids were found to be differentially concentrated, but uniformly down-regulated in RCC. This finding may be the consequence of increased fatty acid oxidation, which has also been described in other cancer types, in particular prostate cancer [21, 22] . Studies identifying fatty acid binding proteins (FABP) [23, 24] and fatty acid synthase [25] [27, 28] .
Another remarkable finding was the profound up-regulation of ␣-tocopherol concentration in RCC and despite previous allusions to such an elevated vitamin E concentration [29, 30] [31] . The increased concentration of ␣-tocopherol has previously been observed in ovarian carcinomas by using similar metabolomics methodology and interpreted as an unspecific stress response [4] . As a potential alternative explanation, elevated vitamin E may indeed play a functional role and render the tumour cell resistant to increased oxidative stress toxic to surrounding normal cell populations. Vitamin E and ␣-tocopherol in particular, is a potent, lipid-soluble, chain-breaking antioxidant and additional vitamin E has been shown to prevent mitochondrial dysfunction in the presence of severe oxidative stress [32] . However, the specific role of vitamin E is likely not limited to its antioxidant function, but can rather be extended to ␣-tocopherol serving as a transcriptional regulator of gene expression [33] . Results which point to the importance of ␣-tocopherol would seem to indicate that further studies are justified to clarify the phenomenon of tocopherol elevation in RCC, which may ultimately be exploited for establishing novel therapeutic targeting strategies [19] . Differentially regulated metabolites may also include intracellular signalling molecules, as indicated by the fact that myoinositol was one of the key metabolites identified in our study. This compound belongs to the inositol polyphosphate family of small cytosolic molecules involved in the control of a wide range of cellular processes [34] . Its downregulation has also been described in prostate cancer [35] .
In [37] . The reduced proline oxidase expression, as described in RCC cell lines [38] , would be an alternative explanation. Altogether, the findings in metastatic RCC merit further studies.
